![Revati Shreeniwas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Revati Shreeniwas
President bij
Revati, Inc.
Profiel
Currently, Revati Shreeniwas is President at Revati, Inc. since 2004 and a Member at Continuing Medical Education, Inc. Formerly, Dr. Shreeniwas was Chief Medical Officer at Bright Minds Biosciences, Inc. from 2020 to 2022, Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017, Vice President-Clinical Development at Soleno Therapeutics, Inc. from 2019 to 2020, Vice President-Clinical Research & Development at Alvine Pharmaceuticals, Inc., Principal at Scios, Inc., Principal at CV Therapeutics, Inc., Principal at The Trustees of Columbia University in The City of New York, Professor at Stanford University.
Actieve functies van Revati Shreeniwas
| Bedrijven | Functie | Begin |
|---|---|---|
Continuing Medical Education, Inc.
 Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Publishes medical magazines and journals | Corporate Officer/Principal | - |
Revati, Inc. | President | 01-01-2004 |
Eerdere bekende functies van Revati Shreeniwas
| Bedrijven | Functie | Einde |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2022 |
| SOLENO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2020 |
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Revati, Inc. | |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Continuing Medical Education, Inc.
Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Publishes medical magazines and journals | Consumer Services |
NeurAxon Pharma, Inc.
NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Bright Minds Biosciences, Inc.
 Bright Minds Biosciences, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
